MRX Stock Recent News

Marex Group plc (NASDAQ:MRX ) Q2 2025 Earnings Conference Call August 13, 2025 9:00 AM ET Company Participants Adam Strachan - Head of Investor Relations Crispin Robert John Irvin - CFO & Director Ian Theo Lowitt - Group CEO & Executive Director Paolo Roberto Tonucci - Chief Strategist & CEO of Capital Markets Conference Call Participants Alexander Blostein - Goldman Sachs Group, Inc., Research Division Alexander Kramm - UBS Investment Bank, Research Division Benjamin Elliot Budish - Barclays Bank PLC, Research Division Carlos Gomez-Lopez - HSBC Global Investment Research Daniel Thomas Fannon - Jefferies LLC, Research Division Patrick Malcolm Moley - Piper Sandler & Co., Research Division William Raymond Katz - TD Cowen, Research Division Operator Good day, and thank you for standing by. Welcome to the Marex Second Quarter 2025 Earnings Conference Call and Webcast.

The headline numbers for Marex Group PLC (MRX) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Marex Group PLC (MRX) came out with quarterly earnings of $1.02 per share, beating the Zacks Consensus Estimate of $0.92 per share. This compares to earnings of $0.9 per share a year ago.

NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Marex Group plc (‘Marex' or the ‘Group'; Nasdaq: MRX) a diversified global financial services platform, providing essential liquidity, market access and infrastructure services to clients in the energy, commodities and financial markets, today reported financial results for the second quarter ('Q2 2025'). Ian Lowitt, Group Chief Executive Officer, stated, “I am delighted with our very strong performance.

SAN FRANCISCO, Aug. 12, 2025 (GLOBE NEWSWIRE) -- On August 5, 2025, investors in Marex Group plc (NASDAQ: MRX) saw the price of their shares significantly decline in the wake of a critical short report accusing the company of engaging in an improper multi-year accounting scheme. The report has triggered national shareholders rights firm Hagens Berman to commence an investigation into whether Marex may have violated the securities laws.